Skip to main content
$2.65 $0.00 (0.0%)

04:00 PM EDT on 05/12/21

Oncolytics Biotech Inc Com (NASDAQ:ONCY)

CAPS Rating: No stars

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.

Current Price $2.65 Mkt Cap $170.4M
Open $2.68 P/E Ratio 0.00
Prev. Close $3.23 Div. (Yield) $0.00 (0.0%)
Daily Range $2.63 - $2.73 Volume 435,089
52-Wk Range $1.52 - $4.83 Avg. Daily Vol. 1,590,459

Caps

How do you think NASDAQ:ONCY will perform against the market?

Add Stock to CAPS Watchlist

All Players

74 Outperform
25 Underperform
 

All-Star Players

5 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ONCY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (58.66)
Submitted January 31, 2020

I first got interested in ONCY about 20 years ago. Bought in a couple of times. Lost some money. Since then I've watched a legacy of dilution, reverse stock splits, mismanagement, and stagnation. I feel like the protagonist in The Offspring song Self… More

sleepyseth (99.30)
Submitted November 04, 2006

I hate to go so against the grain on this one and be the only bear, but its stock looks like it is heading lower to me. They just don't have anything that they can commercialize soon enough. Nothing in Phase III yet and they losing $10 million a… More

Recent Community Commentary

Read the most recent pitches from players about ONCY.

Recs

1
Member Avatar odocoileus (58.66) Submitted: 1/30/2020 11:38:01 PM : Outperform Start Price: $2.61 NASDAQ:ONCY Score: -21.64

I first got interested in ONCY about 20 years ago. Bought in a couple of times. Lost some money. Since then I've watched a legacy of dilution, reverse stock splits, mismanagement, and stagnation. I feel like the protagonist in The Offspring song Self Esteem. You know, “I know I'm being used, but that's OK because I like the abuse.” How is this company still around? They're like a cockroach with smoke coming off its carapace crawling from the central core of that nuclear reactor that just went critical.

I know what you're thinking: is this guy aware he green-thumbed this? Well, yes I am. Yes, I am. So here it is: I'm a sucker for interesting science, but also for a good story. Instead of altering genes or antibodies or manipulationg a single checkpoint that someone discovered through painstaking work, someone had the bright idea to let evolution home in on whatever various and sundry ways a virus uses to select cells and let them do the job a thousand scientists couldn't figure out. Simple, elegant … or maybe just lucky. I don't care.

So I've been waiting for ONCY to either go away for good or actually find a way to use this idea. Rather than try to fit a virus to a cancer, they've been looking for a cancer to fit a virus. Not sure that would have been my approach, but maybe they got it right. It appears that reovirus has an affinity for KRAS and CEACAM6. So if you can screen for biomarkers indicating these mutation, you may get a high response in that subset. LOXO got a drug approved based on a mutation rather than a cancer type, and I think we'll see more of this approach in the future.

Combination therapy with checkpoint inhibitors looks to be even more effective as reovirus has a way of exposing the cancer cell to the immune system. I think 2020-2021 will be the year that ONCY is either going to break through or flame out for good. But I'm a glass half full sort of guy, and I'm rooting for this one. They've shown some good progress in early trials, but they still have a long way to go. They have some big partners and any success could greatly affect the market cap and therefore he share price of this tiny company.

Recs

0
Member Avatar PrometheusX (< 20) Submitted: 7/10/2015 6:31:00 PM : Outperform Start Price: $0.60 NASDAQ:ONCY Score: +249.35

ONCY is on the verge of having a breakthrough in treatment of a disease of civilization. Now very undervalued and with a possible future standard medication for cancer(s) in hand.

Recs

0
Member Avatar bobfarr (< 20) Submitted: 3/11/2015 8:40:24 AM : Outperform Start Price: $0.79 NASDAQ:ONCY Score: +139.23

On the cutting edge of cancer fighting viruses.

Leaderboard

Find the members with the highest scoring picks in ONCY.

Score Leader

brwn8484

brwn8484 (< 20) Score: +1,165.90

The Score Leader is the player with the highest score across all their picks in ONCY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
BadCopNoDonuts < 20 9/24/2010 Underperform 5Y $4.75 -44.00% +256.40% +300.40 0 Comment
vbaci 27.87 9/28/2010 Underperform 5Y $4.74 -43.88% +254.44% +298.32 0 Comment
Smog79 < 20 9/28/2010 Underperform 3W $4.77 -44.23% +253.95% +298.18 0 Comment
chippybeck < 20 9/24/2010 Underperform 5Y $4.40 -39.52% +253.48% +293.00 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $2.69 -1.12% +266.16% +267.27 0 Comment
Elwavinator < 20 12/29/2009 Underperform 1Y $2.67 -0.37% +259.55% +259.92 0 Comment
cchigga 85.86 1/31/2012 Underperform 3W $4.61 -42.30% +207.08% +249.38 0 Comment
PrometheusX < 20 7/13/2015 Outperform 1Y $0.60 +343.33% +93.99% +249.35 1 Comment
Schwab711 99.05 2/17/2015 Outperform 5Y $0.62 +329.03% +93.61% +235.43 0 Comment
mungerishx 99.25 1/9/2013 Underperform 5Y $3.60 -26.11% +177.93% +204.04 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ONCY.